Company intelligence / Profile preview

Chemydur

Lahore, Punjab, Pakistan

Ownership: Private
Development stage: Other

Overview

Chemydur is a pharmaceutical company primarily known for its manufacturing and marketing of cardiovascular medications, most notably its namesake brand of Isosorbide Mononitrate. The company operates as a private limited entity, focusing on the production of essential medicines for chronic conditions such as angina and heart failure. Chemydur's business model centers on providing high-quality generic formulations and established therapeutic brands to regional markets. Its product portfolio includes various dosages of vasodilators designed for the long-term management of coronary artery disease.

Therapeutic areas: Cardiovascular
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Chemydur.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chemydur.

Explore the full profile